Creador
General
Grapevine: Leeford, Creador, Neo Group, Ambit Capital in news
Generic drugmaker Leeford Healthcare is in advanced talks with Creador to sell a minority stake; Neo Group plans to ......
Healthcare
Pine Labs backer Vitruvian Partners in talks for stake in local pharma firm
Global investment firm Vitruvian Partners is in advanced stage of talks to invest in domestic formulations manufacturer......
TMT
How did Creador's full exit from India tech portfolio pan out?
Creador, the South- and Southeast Asia-focused private equity firm founded by Brahmal Vasudevan, has sold its entire ......
Healthcare
Creador stares at a tepid exit from nine-year-old healthcare portfolio firm
Creador, the Malaysia-headquartered private equity firm that invests across Southeast Asia and India, is planning to ......
People
Senior executive exits alternative asset manager HQ Capital
A senior executive at HQ Capital, a global independent alternative investment manager, has quit the firm after nearly a ......
Healthcare
Creador-backed Paras Healthcare sees growth opportunities as it revives IPO plan
Hospital operator Paras Healthcare Ltd is upbeat about expanding into smaller cities in northern India and will continue......
Finance
Helion Ventures logs off from 16-year-old housing finance bet
Helion Venture Partners, a venture capital firm that raised three funds between 2006 and 2012 before its founders went ......
Consumer
Samara, four other PE firms get exit window as portfolio company merging with bigger peer
Samara Capital and four other private equity firms are getting an opportunity to monetise their investments in a ......
Finance
Flashback 2025: How the IPO boom helped PE, VC investors mint money again
India’s primary market remained buoyant in 2025, paving the way for private equity and venture capital investors to ......
Healthcare
Creador buys into La Renon as Peak XV makes a partial exit
Private equity firm Creador said Monday it has acquired a 7% stake in Ahmedabad-based La Renon Healthcare Pvt Ltd from ......








